More recent discoveries found frameshift mutations in exon 9 in the calretikulin (CALR) gene in the majority of JAK2- and MPL-negative PMF and ET, causing a 5-bp insertion or a 52-bp deletion [5,16,17,18]. The gene discussed is JAK2; the disease is essential thrombocythemia.